| Literature DB >> 33046213 |
Sebastian Korb1,2, Sebastian J Götzendorfer2, Claudia Massaccesi3, Patrick Sezen4, Irene Graf4, Matthäus Willeit4, Christoph Eisenegger2, Giorgia Silani3.
Abstract
The observation of animal orofacial and behavioral reactions has played a fundamental role in research on reward but is seldom assessed in humans. Healthy volunteers (N = 131) received 400 mg of the dopaminergic antagonist amisulpride, 50 mg of the opioidergic antagonist naltrexone, or placebo. Subjective ratings, physical effort, and facial reactions to matched primary social (affective touch) and nonsocial (food) rewards were assessed. Both drugs resulted in lower physical effort and greater negative facial reactions during reward anticipation, especially of food rewards. Only opioidergic manipulation through naltrexone led to a reduction in positive facial reactions to liked rewards during reward consumption. Subjective ratings of wanting and liking were not modulated by either drug. Results suggest that facial reactions during anticipated and experienced pleasure rely on partly different neurochemical systems, and also that the neurochemical bases for food and touch rewards are not identical.Entities:
Keywords: dopamine; facial EMG; food; human; neuroscience; opioids; reward; social touch
Mesh:
Substances:
Year: 2020 PMID: 33046213 PMCID: PMC7553773 DOI: 10.7554/eLife.55797
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140